UnitedHealth Group Inc. (UNH)

233.61
NYSE : Health Services
Prev Close 229.02
Day Low/High 231.54 / 236.56
52 Wk Low/High 208.07 / 287.94
Avg Volume 3.65M
Exchange NYSE
Shares Outstanding 947.68M
Market Cap 218.06B
EPS 12.40
P/E Ratio 17.33
Div & Yield 4.32 (1.61%)

Political Impact of 2 Issues

Two items are forcing the marketplace to take note as the morning unfolds. One, We already know that the Trump administration has long opposed the Affordable Care Act. The president has at least been smart enough to insinuate that the GOP not take t...

Complexity Theory, Operation Un-Twist, Managed Care Stocks: Market Recon

Complexity Theory, Operation Un-Twist, Managed Care Stocks: Market Recon

It becomes difficult to own for anything other than a trade, managed care stocks and those that most benefit from Medicare expansion.

Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith

Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith

I think sometimes the best way to parse the temperament is to go over the most obviously 'wrong' moves and address why they might not be wrong at all.

Markets, Trade Deal, Cyber Attacks, My ZTO Play: Market Recon

Markets, Trade Deal, Cyber Attacks, My ZTO Play: Market Recon

National security is job one. Cutting a nice deal with China that benefits both sides must come second.

Jim Cramer: It's Crunch Time

Jim Cramer: It's Crunch Time

Don't forget we are oversold. But the fear of missing out is gone.

Fighting the Good Fight vs. a System That Values Speed Over Price: Market Recon

Fighting the Good Fight vs. a System That Values Speed Over Price: Market Recon

If we didn't know where the algorithms that now control the point of sale were lined up before Monday, we sure know now.

UnitedHealth Group Could Fall Further - Defense Coming Onto the Field

UnitedHealth Group Could Fall Further - Defense Coming Onto the Field

Let's see what we can glean from the charts and indicators.

Trump Administration Is No Friend to Pharmacy Benefit Managers Like CVS

Trump Administration Is No Friend to Pharmacy Benefit Managers Like CVS

Pharmacy Benefit Managers (PBMs) are in for some problems if proposed regulation is given approval.

Alphabet's Healthcare Initiative Squares Off With Amazon, Apple

Alphabet's Healthcare Initiative Squares Off With Amazon, Apple

Healthcare is attracting some very healthy competition among mega-cap names.

Jim Cramer: Netflix Shows Just How Powerful the Subscriber Business Is

Jim Cramer: Netflix Shows Just How Powerful the Subscriber Business Is

Netflix has been underpricing its product in order to hook subscribers on its terrific content.

I'm Focused on Stalking an Entry Point for an Index Short

I'm Focused on Stalking an Entry Point for an Index Short

I continue to have a very difficult time finding individual stocks that I want to buy at this juncture.

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Do we have to run for the hills? Not necessarily.

Jim Cramer: Why Wouldn't You Own Apple Stock?

Jim Cramer: Why Wouldn't You Own Apple Stock?

Has the sun set on what was the greatest wealth creator of any company when the stock traded north of a trillion dollars? No.

Jim Cramer: What to Buy in This Treacherous Market

Jim Cramer: What to Buy in This Treacherous Market

Look for the big-cap stocks that only come in on tough days -- and take advantage of their weakness at the open.

Jim Cramer: The Operative Term for This Tape Is Treacherous

Jim Cramer: The Operative Term for This Tape Is Treacherous

Use it to your advantage or don't use it at all.

Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow

Jim Cramer: Why the Market Did What It Did Today and What Can Happen Tomorrow

Now for those of you haven't voted, please go and do so and don't vote this stuff just invest in it!

2 Plays on UnitedHealth Amid the Market Wreckage: Market Recon

2 Plays on UnitedHealth Amid the Market Wreckage: Market Recon

This name has significantly outperformed both the S&P 500 and the health care sector over the course of this awful month

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

Here Are 9 Takeaways From Last Night's Meltdown: Market Recon

It becomes difficult for me to tell you where to run in these markets...

UnitedHealth Has Made a Long Rise, but an EKG of the Indicators Gives Us Pause

UnitedHealth Has Made a Long Rise, but an EKG of the Indicators Gives Us Pause

Let's review the charts and indicators of this health care leader.

UnitedHealth Group: A Steady Performer With Room to Run

UnitedHealth Group: A Steady Performer With Room to Run

When looking at UNH stock, you're looking at reliability.

Jim Cramer: An Absence of Negatives Is a Real Positive

Jim Cramer: An Absence of Negatives Is a Real Positive

This is what the market looks like when the Fed says nothing and the president isn't ranting about something.

Here's How to Play Adobe on Killer Growth Forecast: Market Recon

Here's How to Play Adobe on Killer Growth Forecast: Market Recon

Adobe released new guidance for the rest of this year and 2019. With 20% growth in the cards, this name is a buy.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: Valuations Now Have No Relation to Common Sense

Jim Cramer: Valuations Now Have No Relation to Common Sense

Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Jim Cramer: These CEOs Deserve the Benefit of the Doubt

Sometimes you gotta have faith, but you also have to be a little more skeptical.

Jim Cramer: I Want the Cigna-Express Scripts Deal to Close

Jim Cramer: I Want the Cigna-Express Scripts Deal to Close

Activist investor Carl Icahn slammed Cigna's move to acquire Express Scripts.

Jim Cramer: Trade Wars and Tariffs May Soon Be Baked Into Pricing

Jim Cramer: Trade Wars and Tariffs May Soon Be Baked Into Pricing

Earnings have been strong, and analysts will soon start to concentrate more on actual weakness than shadow-boxing weakness.

Futures Lower on Trade Worries and 4 Other Stories to Watch Thursday

Futures Lower on Trade Worries and 4 Other Stories to Watch Thursday

Keep an eye on these business stories as stocks point lower on trade concerns.

Jim Cramer: With the FANG Stocks, It's One for All and All for One

Jim Cramer: With the FANG Stocks, It's One for All and All for One

The relentless emphasis on the FANG four has spawned the 'Dumas effect,' as ETFs force these stocks to trade together.